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http:WHAT THIS PAPER ADDS
When screening 70-year-old men for AAA, the prevalence was 2.3%, which is less than half the predicted. The
attendance rate was 84.0% and smoking was the strongest risk factor for AAA. The total known prevalence in the
population was 3.0%; thus almost 40% of the men with AAAs were already known from other means, hence
questioning the beneﬁt of screening 70- instead of 65-year-old men, since only men with unknown AAAs have
anything to gain from screening.Background: Screening 65-year-old men for abdominal aortic aneurysms (AAA) is a cost-effective method to
reduce the mortality from ruptured AAA. However, contemporary results show a lower than expected prevalence
of AAA, thus questioning the beneﬁt of screening. Since the prevalence increases with age, a possible way to
enhance the beneﬁt of screening might be to screen older men. Our aim was to determine the contemporary
screening-detected prevalence among 70-year-old men.
Methods: A total of 5,623 unscreened 70-year-old men were invited to ultrasound screening. Uni- and
multivariable analyses were used to assess the risk factors for AAA.
Results: The attendance rate was 84.0%. The prevalence of previously unknown AAAs was 2.3%.When adding the
64 men with an already known AAA to the screening-detected ones, the total prevalence in the population was at
least 3.0%, and the previously discovered AAAs constituted 37.4% of the total prevalence. “Ex smoker” and
“Current smoker” were the most important risk factors.
Conclusions: When screening 70-year-old men for AAA, the prevalence was less than half that expected, despite
a high attendance rate. Smoking was the strongest risk factor. Almost 40% of the men with AAAs were already
known from other means than screening.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Ruptured abdominal aortic aneurysm (rAAA) is a common
cause of death, especially among elderly men, with an
overall mortality of at least 75%.1 In Sweden, approximately
600 people die from this annually, comprising 1% of the
total mortality among men older than 65 years of age.1 A
cost-effective method of reducing the mortality from rAAA
by half is by screening 65-year-old men for AAAs and sur-
veillance those found.2 Aneurysm repair should be consid-
ered when the risk of rupture is greater than the risk of the
surgical treatment, that is at an AAA diameter of approxi-
mately 5.5 cm.3 Screening for AAA is now adopted around
the world and is practically nationwide in, for examplerresponding author. J. Hager, Department of Cardiovascular Surgery,
ity Hospital, SE-58185 Linköping, Sweden.
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//dx.doi.org/10.1016/j.ejvs.2013.07.014England, Scotland, and Sweden, and in the United States as
part of the Medicare-programme.4 However, in recent
studies concerning 65-year-old men, a prevalence of 1.6e
1.7% has been found, which is only one-third of the 4.9%
that has previously been estimated by using a meta-analysis
of studies reporting the prevalence in speciﬁcally 65-year-
old men.4e7
As the prevalence of AAA seems to increase with age,
there is an ongoing debate whether screening of men older
than 65 years might increase the efﬁcacy of screening.5,8,9
The aims of the study were to determine the contem-
porary screening-detected prevalence of AAA among pre-
viously unscreened 70-year-old men and to deﬁne potential
risk factors and their association to AAA.
METHODS
The study-population consisted of all men in Östergötland,
Sweden, becoming 70 years old (born 1938e40) during
2008e2010. They had not previously been screened for
454 J. Hager et al.AAA and they were identiﬁed through the National Popu-
lation Registry, and with 2 weeks notice all, without any
exclusion criteria, were invited to an ultrasound examina-
tion of the infrarenal aorta. If they were not able to attend
the examination, they were urged to re-book by phone or
Internet. One reminder was sent to those who did not
attend or reply. The examination was free of charge but no
travel expenses were reimbursed.
In order to increase the attendance rate we used a
decentralized way of screening in that the examination was
carried out at two of the three hospitals in the region and in
addition at seven district health care centres. The exami-
nation was carried out by an experienced technician, using
a portable ultrasound machine (GE Vivid i from General
Electric Health Care, Waukesha, WI, USA) with a 4C-RS
probe (1.8e6.0 MHz). All together nine dedicated techni-
cians, working in pairs, specialized in ultrasound examina-
tions of the peripheral arterial tree, performed the scans.
Fasting was not demanded and the standard position was
supine. If the aorta was difﬁcult to visualize, other positions
were used and/or the other technician tried to visualize the
aorta. If the aorta still not could be visualized, the subject
was invited for a new attempt, but now during fasting.
Weight and height were also measured. Along with the
invitation, an information leaﬂet concerning AAA was
enfolded, as well as a Health Questionnaire to be completed
prior to examination, in order to diminish recall bias. The
questionnaire contained questions regarding heredity con-
cerning AAA, smoking habits, current medication, and
presence or absence of the following diseases: hyperten-
sion, hyperlipidaemia, diabetes mellitus, chronic obstructive
pulmonary disease (COPD), renal disease, cerebrovascular
disease (CVD), claudication, coronary heart disease (CHD)
reﬂected as angina pectoris and/or myocardial infarction,
rheumatic disease, and cancer. All these data were self-
reported.
An AAA was deﬁned as the infrarenal aortic diameter
being 30 mm. The aorta was scanned with the probe in
the transverse (horizontal) position and then in the sagittal
(vertical) position. The greatest anteroposterior (AP) diam-
eter of the aorta was measured according to the “leading-
edge-to-leading-edge” principle.10
From local databases men born 1938e40 with an already
known AAA under surveillance were identiﬁed and excluded
from the cohort, since our intention was to study men withTable 1. The prevalence of abdominal aortic aneurysm (AAA) among m
Study Mean age
(years)
Numbers of patien
studied
ADAM8 66 126,196a
Lindholt et al.15 67.5 4,843
MASS16 69 27,147
Simoni et al.17 69 741
Norman et al.18 73 12,203
Bengtsson et al.19,20 74 375
Ljungberg et al.21 78.6 212
NA ¼ information not available.
a 97% men.screening-detected AAA. With aid of the Swedish Vascular
Registry (Swedvasc, a nationwide register with a docu-
mented high validity) all men in our cohort who had already
been treated for an AAA were identiﬁed and excluded for
the same reason.11,12
The chi-square test with continuity correction was used
for the univariate analysis, and when the validity of the chi-
square test was in question (too small expected numbers in
any cell of the 2  2 table) the result was checked with the
Fisher test. Univariate analyses for testing differences in
continuous variables were made with a t test. Logistic
regression was used for the multivariable analysis and
variables with p < .1 from the univariate chi-square test
entered into the multivariable logistic regression (“glm” in
the R-package).13,14 The different risk factors and medica-
tions were entered as being present or absent in the logistic
regression.
The relative risk of differences in body mass index (BMI)
for the prevalence of AAA was calculated by exponentiation
of the predicted log odds (from logistic regression) to odds,
by transforming odds to probabilities, and ﬁnally the quo-
tient of the probabilities of the two BMIs of interest.
The expected point prevalence for 70-year-old men was
calculated by using data from previous studies concerning
men 66 years of age by means of a multiple linear
regression analysis (“lm” in the R-package)13,14 weighted for
the number of men in each study used (Table 1).8,15e21
Calculations and statistical analyses were performed in
the R-language from the R-Project for Statistical
Computing13 and Microsoft Excel (Microsoft Corporation,
Redmond, WA, USA) was used as a database.
The Regional Ethical Review Board in Linköping approved
the study.RESULTS
Altogether 5,623 men who reached 70 years old during the
years 2008e2010 and were invited to screening. The
attendance rate was 84.0%, and of the 4,721 that attended
six men were excluded, three due to poor visibility on ul-
trasound examination and three because they already had a
known AAA under surveillance. The ﬁnal screening cohort
was 4,715.
The mean aortic diameter was 19.7 mm: 93.4% of the
men had an aortic diameter <25 mm and 4.3% had aen 66 years of age in previous studies.
ts Attendance rate (%) Prevalence of AAA (%)
NA 4.19
76.4 3.94
80.2 4.91
NA 8.77
63.1 7.17
75.2 8.27
NA 8
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with a screening-detected AAA had an aneurysm of
>54 mm in diameter, thus requiring evaluation for surgical
treatment. Of the 107 AAAs, the vast majority, 93 (87%),
were <40 mm in diameter.
Thirteen men with a former known AAA did not attend
screening and neither did 38 of the 48 men previously
treated for an AAA/rAAA. Of the 10 who had been treated
and who attended, one had developed a new AAA (32 mm
in diameter) proximal to the graft. The screening-detected
AAA prevalence was 2.3% (n ¼ 107). Adding the 48 men
who already had been treated for an AAA/rAAA and the 16
men with non-screening-detected AAA to the screening-
detected AAAs, the total known prevalence was at least
3.0% (171/5623); therefore, 64 (37.4%) of the AAAs wereTable 2. Univariate comparison between 70-year-old men with or wit
70-year-old men born 1938e1940,
n ¼ 4715
AAA 2.3% Complete
registrations (
Risk factor
First-degree relative with AA 6.5 100
Previous rAA operation 1.9 100
Previous AA operation 1.9 100
Never smoked 11.2 100
Ex-smoker 56.1 100
Current smoker 32.7 100
Hypertension 52.9 97
Hyperlipidaemia 42.9 85
Diabetes mellitus 18.3 97
CHD 27.2 96
COPD 13.7 95
Renal disease 6.7 97
Cerebrovascular disease 16.3 97
Claudication 5.7 98
Rheumatic disease 7.7 97
Cancer 4.8 97
No medication 34.0 99
Vitamin K-antagonists 6.7 98
Heparin-group 0.0 97
Thrombocyte inhibitors 43.8 98
Cardiac glucocides 1.9 97
Antiarrhytmics 1.0 98
Vasodilators 3.8 97
Diuretics 18.3 97
Beta-receptor blockers 34.3 98
Calcium antagonists 21.1 97
Renineangiotensin inhibitors 32.3 98
Other antihypertensives 0.0 97
Serum-lipid lowering agents 44.8 98
Corticosteroids 2.9 97
Cytotoxic agents 2.9 97
Immunosuppressive agents 0.0 97
Anti-inﬂammatory drugs 2.9 97
Opoids 0.9 97
Height, mean (m) 1.77 98
Weight, mean (kg) 85.2 98
BMI (kg/m2) 27.5 97
CHD ¼ coronary heart disease; COPD ¼ chronic obstructive pulmo
Aneurysm, rAA ¼ ruptured AA, CHD ¼ Coronary Heart Disease, COP
Index (weight/length2).already known or had been previously treated in this
cohort.
In Table 2 the results from the univariate analysis testing
for potential risk factors for AAA are shown. The most sig-
niﬁcant risk factors were “Current smoker”, “CHD”, and
“Renal disease”, all reaching p < .001. For those individuals
who were “Ex smokers” the prevalence of AAA was 2.5%
and for those who were “Current smokers” the prevalence
was 5.5%, compared with 0.65% among those who had
”Never smoked”.
An increased BMI was found among the men with an
AAA, p < .01, compared with those without (t test). From a
logistic regression analysis on BMI and AAA, we found that
two BMI steps, for example from 25 to 27 kg/m2, which in a
man who is 1.77 m tall and weighs 83 kg is slightly morehout abdominal aortic aneurysm (AAA).
%)
Normal aorta
97.7%
Complete
registrations (%)
p Value
(chi-square test)
4.9 99 .59
0.2 99 <.05
0.6 99 .27
38.2 99 <.001
50.1 99 .26
11.7 99 <.001
44.5 95 .11
31.0 88 <.05
15.4 96 .50
13.6 97 <.001
6.6 96 <.01
1.5 97 <.001
7.3 97 <.01
1.5 97 <.01
5.5 97 .46
11.4 97 <.1
42.4 99 .10
6.9 97 1.0
0.2 97 1.0
26.4 98 <.001
0.9 97 .57
0.4 97 .86
3.5 97 1.0
14.2 97 .30
25.3 98 <.05
14.4 97 <.1
28.4 98 .43
0.4 97 1.0
31.0 98 <.01
2.1 97 <.84
0.7 97 <.1
0.4 97 1.0
1.9 97 0.75
1.4 97 1.0
1.77 99 e
82.9 100 e
26.6 99 <.01 with t test
nary disease.AAA ¼ Abdominal Aortic Aneurysm, AA ¼ Aortic
D ¼ Chronic Obstructive Pulmonary Disease, BMI ¼ Body Mass
Figure 1. The predicted prevalence for 70-year-old men was 5.7%,
using data from previous studies (ﬁlled circles, from left to right:
ADAM,8 Lindholt,15 MASS,16 (below line), Simoni17 (above line),
Norman,18 Bengtsson et al.,19,20 and Ljungberg et al.21) concerning
men 66 years of age (Table 1), weighted for the number of men
in each study, r ¼ .91, p ¼ .003. The prevalence in this study was
2.3% (unﬁlled circle), thus less than half the predicted, p ¼ .0014.
456 J. Hager et al.than 6 kg, increased the probability of having an AAA by
19.0% (relative risk).
Ten risk factors (excluding medication) had p < .1 in the
univariate analysis and these were tested in a multivariable
logistic regression analysis (Table 3). Of the 4,715 men in
the screening cohort, 3,872 had complete registrations
regarding these risk factors. The two risk factors “Ex
smoker” and “Current smoker” remained the strongest risk
factors, OR 3.3 (95% CI 1.7e6.6) and 8.9 (95% CI 4.2e18.6)
respectively, p < .001 for both. Also the risk factors “Renal
disease”, COPD, and CVD remained associated with AAA.
When we included body mass index (BMI) in the multi-
variable analysis, no major changes with respect to the
association between AAA and the other risk factors
occurred. We did not include BMI in the ﬁnal multivariable
analysis, since overweight in itself is not a disease, as long
as BMI is <30. Instead, quite small changes in BMI were
associated with changes in risk for an AAA.
DISCUSSION
The main ﬁnding of this screening study, comprising almost
5,000 Swedish 70-year-old men, was the low prevalence of
AAA (2.3%).
By using data from previous studies concerning men 66
years of age, we calculated the expected AAA-prevalence
for 70-year-old men (Fig. 1) to 5.7% (r ¼ 0.91 and
p ¼ .03), and the prevalence in our screening-study of 2.3%
was signiﬁcantly lower (p ¼ .014), less than half the pre-
dicted for this age.
When including men with already known AAAs, the total
known prevalence was at least 3.0%, thus almost 40% of all
the men with AAAs were already treated or under surveil-
lance. However, only subjects with undetected AAAs have
anything to gain from a screening programme.
Smoking is the most important known risk factor for AAA
and the excess prevalence for AAA associated with smokingTable 3. Multivariable logistic regression analysis of variables
associated with the presence of an abdominal aortic aneurysm.
Risk factor Odds ratio Conﬁdence
interval (95%)
p-Value
Previous rAA-surgery 12.4 2.1e74.8 p < 0.01
Never smoked Reference
Ex smoker 3.3 1.7e6.6 p < 0.001
Current smoker 8.9 4.2e18.6 p < 0.001
Renal disease 3.2 1.2e8.4 p < 0.05
COPD 2.1 1.1e3.9 p < 0.05
CVD 2.0 1.1e3.6 p < 0.05
Claudication 2.0 0.7e5.6 p ¼ 0.18
CHD 1.7 1.0e3.0 p ¼ 0.053
Hyperlipidaemia 1.2 0.8e2.0 p ¼ 0.37
Cancer 0.4 0.1e1.1 p ¼ 0.079
Note. Variables with p < .1 in the univariate analysis, Table 2, were
included in the multivariable analysis. The number of complete
observations used in the analysis is 3872 (of 4,715 in the
screening cohort). AAA ¼ aortic abdominal aneurysm;
rAA ¼ ruptured aortic aneurysm; COPD ¼ chronic obstructive
pulmonary disease; CVD ¼ cerebrovascular disease;
CHD ¼ coronary heart disease.accounts for 75% of all AAAs 4 cm.8 Smoking correlates
with increased expansion of AAA, increased risk of rupture,
poorer long-term survival, and quitting smoking may reduce
growth rate of small AAAs.22e24
We also found strong associations between the risk fac-
tors “Ex smoker” and AAA, and “Current smoker” and AAA,
odds ratio being 3.3 and 8.9 respectively.
Approximately 20% of AAA patients have previously
been shown to have a ﬁrst-degree relative with the dis-
ease.8,25e27 In our study, having a ﬁrst-degree relative with
AAA was not a signiﬁcant predisposing factor for AAA. The
explanation for this might be that in Sweden many AAA
patients are urged to encourage their ﬁrst-degree relatives
to have their aorta examined. This might also be one reason
for the high incidental ﬁnding of AAA.
In the UK Endovascular AAA Repair 1 (EVAR 1), the Dutch
Randomized Endovascular Aneurysm Repair (DREAM), and
the Open Versus Endovascular Repair (OVER) trials, a pos-
itive correlation between AAA and cancer was found, and
mortality due to cancer was considerably higher than AAA-
related or cardiovascular mortality.28e30 The reason for the
cancereAAA correlation is probably due to the joint relation
with smoking.
To our surprise, we found a tendency to a lower AAA
prevalence among men with cancer, OR 0.4 (95% CI 0.1e
1.1), p ¼ .079. One explanation might be that those in-
dividuals who are diagnosed with cancer, almost always are
subjected to a computed tomography (CT) or magnetic
resonance imaging (MRI) scan, which means that any
existing AAA is discovered and thus would be found in the
group of already discovered AAA prior to screening. It is
unknown whether the 64 patients with an already known
European Journal of Vascular and Endovascular Surgery Volume 46 Issue 4 p. 453e459 October/2013 457AAA in our cohort actually had a higher cancer prevalence
than the study population, since we did not have the ethical
permission to review case notes of individual patients.
We found an association between increased BMI and
having an AAA. Being overweight increases the risk for AAA
although the effects are small compared with age, gender,
and smoking.26,31,32
Diabetes mellitus (DM) has in prior works been shown to
be a protector against AAA.8,33 In our cohort of 70-year-old
men, the AAA prevalence was not lower among diabetics.
One reason for this might be that with increasing age, the
protective effect of DM decreases as other factors
contributing to the development of AAA, for example
atherosclerosis, become more dominant.
The lower than predicted AAA prevalence reported in this
study is in line with the prevalence seen among 65-year-old
men in other contemporary studies.5,6,9,34e36
The steep decrease in daily smoking in Sweden (Fig. 2)
and in the rest of the Western world might be one cause for
the decline in AAA prevalence, since smoking is the stron-
gest risk factor for having an AAA.37 Thus, in countries with
similar development regarding smoking habits as in Swe-
den, the prevalence of AAA among 70-year-old men may be
expected to be as low as in this study.
The use of lipid-lowering agents, treatment with
angiotensin-converting enzyme (ACE) inhibitors and overall
better regulation of hypertension have also been suggested
as contributors to the declining prevalence.38e40 No asso-
ciations pointing in this direction were found in this cohort;
on the contrary, the use of lipid-lowering agents, throm-
bocyte inhibitors, and beta-receptor blockers were already
signiﬁcantly more common among those with a screening-
detected AAA, indicating an already known greater cardio-
vascular morbidity.26 The men with an AAA were also
signiﬁcantly more affected by renal disease, COPD, and
CVD; however, and a bit surprising, diseases normally
associated with atherosclerosis and smoking, for example
claudication, CHD, and hyperlipidaemia, failed to prove fully
signiﬁcant in our study. Most likely the diseases associated
with smoking are also associated with each other andFigure 2. Percentage of Swedish men, 16e84 years old, smokingtherefore may fail to show up in the multivariable analysis
as independent risk factors for AAA. Thus, if patients with
smoking-associated diseases other than AAA, use of lipid-
lowering agents, thrombocyte inhibitors, and beta-
receptor blockers will also be associated with a higher
prevalence of AAA.
The prevalence of AAA among the 70-year-old men in this
study was higher than the 1.6e1.7% rate reported from
screening 65-year-old men.4e6 This might be considered a
reason to raise the age threshold for screening. However,
almost 40% of all known AAAs in the population had
already been discovered, contradicting this notion.5,9
Another possible explanation for the high rate of inciden-
tally found AAAs (besides screening of relatives and CT/MRI
scans among cancer patients, as discussed above) might be
the trend, at least in Sweden, towards performing more
advanced radiological examinations also in the acute
setting, such as CT-scans, where most AAAs are easily seen.
We experienced a high attendance rate e 84%. The fact
that we utilized a partly decentralized screening method
and that the examination was free of charge might have
contributed to this. Decreasing attendance rate is associ-
ated with increasing prevalence of AAA and social depri-
vation.41 However, despite the high attendance rate in this
study, the screening-detected prevalence was lower than
ever reported previously for this age. Assuming that the
prevalence among those individuals who did not attend
screening is the same as in the rest of this age group, the
estimated total AAA prevalence in the population would be
2.3% þ 64/5,623 ¼ 3.4%.
In conclusion, when screening 4,715 70-year-old men in
Östergötland, Sweden, for AAA, we found the lowest ever
reported prevalence for this age, 2.3%, less than half the
predicted prevalence. When including those men who
already had been treated for an AAA or were under sur-
veillance, the total known prevalence was at least 3.0%;
thus almost 40% of the AAAs were incidentally found. The
most important risk factor for AAA was smoking.
The present study does not lend support to the notion
that screening at an age higher than 65 years would resulton a daily basis, 1980e2005. From Statistics Sweden (SCB).37
458 J. Hager et al.in detection of substantially more AAAs, since such a large
part of the AAAs are already detected by means other than
screening.
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